STAA fundamentals
STAAR Surgical Company revenue breakdown overview
STAAR Surgical Company revenue for the last year amounted to 313.90 M USD, the most of which — 312.54 M USD — came from its highest performing source at the moment, Implantable Collamer Lenses, the year earlier bringing 319.43 M USD. The greatest contribution to the revenue figure was made by China — last year it brought STAAR Surgical Company 161.32 M USD, and the year before that — 185.55 M USD.
By source
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
90.00 M
180.00 M
270.00 M
360.00 M
Implantable Collamer Lenses
Other Surgical Products
Cataract Intraocular Lenses
Ophthalmic Surgical Product
Currency: USD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Implantable Collamer Lenses
141.41 M
212.91 M
269.71 M
319.43 M
312.54 M
Other Surgical Products
8.48 M
5.05 M
5.04 M
1.85 M
1.36 M
Cataract Intraocular Lenses
13.57 M
12.52 M
9.64 M
1.14 M
—
Ophthalmic Surgical Product
—
—
—
—
—
By country
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
90.00 M
180.00 M
270.00 M
360.00 M
China
Japan
United States
Other
South Korea
Spain
France
Germany
Australia
Currency: USD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
China
71.69 M
107.33 M
148.17 M
185.55 M
161.32 M
Japan
34.99 M
40.97 M
43.09 M
38.47 M
41.84 M
United States
6.16 M
10.10 M
14.68 M
17.22 M
19.90 M
Other
50.62 M
72.07 M
78.45 M
81.17 M
90.85 M
South Korea
—
—
—
—
—
Spain
—
—
—
—
—
France
—
—
—
—
—
Germany
—
—
—
—
—
Australia
—
—
—
—
—